events
Dietmar Reusch | Fleming
Linkedin

Dr. Dietmar Reusch

Director Development & Characterization
Roche Diagnostics, Germany
After his study of Chemistry with focus on analytics at the University for Applied Science Reutlingen, Germany with a degree as graduate engineer in chemistry, Dietmar was engaged at TÜV Stuttgart as specialist of environmental safety. Since 1988 he is working at Roche Diagnostics. At present Dietmar is heading the Characterization Analytics department of Pharma Development at the Roche facility in Penzberg, Germany. In 2015 he has received his PhD (Glycan analysis of therapeutic antibodies) from the University of Amsterdam.
His responsibilities are the characterization and comparability of all large molecules, especially monoclonals in development and production for Roche Pharma Europe. The techniques used in his lab are including mass spectrometry, HPLC-MS, and spectroscopic methods for process development and product release.
His special focus is on glycobiology and glycan analysis with methods like HILIC/RP-UPLC after AB-labeling, HPAEC-PAD, CE, and mass spectrometric based methods, including high-throughput techniques and PK studies with glycovariants.

Events/Masterclasses Dr. Dietmar Reusch is currently speaking at

Pharma

Monoclonal Antibodies
23 - 25 October 2024
Online Live Stream | 13:00 – 17:30 CEST
This unique 3-day course is designed for advanced persons & specialists in the field of protein therapeutics or participants who have emphasis to jump into this exciting new business field.
See Event

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

Contact us
view all events

REQUEST MORE INFORMATION

Linkedin
Dr. Dietmar Reusch
Director Development & Characterization
Roche Diagnostics, Germany
After his study of Chemistry with focus on analytics at the University for Applied Science Reutlingen, Germany with a degree as graduate engineer in chemistry, Dietmar was engaged at TÜV Stuttgart as specialist of environmental safety. Since 1988 he is working at Roche Diagnostics. At present Dietmar is heading the Characterization Analytics department of Pharma Development at the Roche facility in Penzberg, Germany. In 2015 he has received his PhD (Glycan analysis of therapeutic antibodies) from the University of Amsterdam.
His responsibilities are the characterization and comparability of all large molecules, especially monoclonals in development and production for Roche Pharma Europe. The techniques used in his lab are including mass spectrometry, HPLC-MS, and spectroscopic methods for process development and product release.
His special focus is on glycobiology and glycan analysis with methods like HILIC/RP-UPLC after AB-labeling, HPAEC-PAD, CE, and mass spectrometric based methods, including high-throughput techniques and PK studies with glycovariants.
Dr. Dietmar Reusch
Description